Comparison of changes in cardiac structure after treatment in secondary hypertension

Y Yoshitomi1, T Nishikimi, H Abe

  • 1Division of Hypertension and Kidney Disease, National Cardiovascular Center, Osaka, Japan.

Insights

Aldosterone and high blood pressure contribute to left ventricular hypertrophy in secondary hypertension. While high blood pressure is key in renovascular hypertension, aldosterone excess and volume expansion play roles in primary aldosteronism.

Area of Science:

  • Cardiology
  • Endocrinology
  • Hypertension Research

Background:

  • The relationship between hormonal influences, blood pressure, and left ventricular hypertrophy (LVH) in secondary hypertension is not fully understood.
  • Aldosterone and the renin-angiotensin system are implicated in cardiovascular remodeling.

Purpose of the Study:

  • To investigate the distinct roles of aldosterone and the renin-angiotensin system in cardiac structure, specifically left ventricular hypertrophy, in patients with secondary hypertension.
  • To compare the impact of primary aldosteronism and unilateral renovascular hypertension on LVH.

Main Methods:

  • Echocardiography was performed on 16 patients with primary aldosteronism and 11 with unilateral renovascular hypertension before and after treatment.
  • Blood pressure and hormonal levels were monitored. Patients underwent surgical or interventional treatment to normalize blood pressure.

Main Results:

  • Both groups achieved normalized blood pressure post-treatment, with no significant pre-treatment differences in LVH.
  • Left ventricular mass index significantly decreased in both groups after treatment.
  • In primary aldosteronism, changes in left ventricular internal dimension correlated with LVH changes (r=.58). In renovascular hypertension, blood pressure changes correlated with LVH changes (r=.77).

Conclusions:

  • High blood pressure significantly contributes to LVH in unilateral renovascular hypertension.
  • Expanded plasma volume from aldosterone excess and hypertension are key factors in LVH development in primary aldosteronism.
  • Different mechanisms modulate LVH development in distinct types of secondary hypertension.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...